Also known as: 912444-00-9, Abt-888, Abt 888, Abt-888 (veliparib), Veliparib free base, Abt888

Molecular Formula

C₁₃H₁₆N₄O

Molecular Weight

244.29 g/mol

InChI Key

JNAHVYVRKWKWKQ-CYBMUJFWSA-N

FDA UNII

01O4K0631N

Veliparib is a poly(ADP-ribose) polymerase (PARP) -1 and -2 inhibitor with chemosensitizing and antitumor activities. With no antiproliferative effects as a single agent at therapeutic concentrations, ABT-888 inhibits PARPs, thereby inhibiting DNA repair and potentiating the cytotoxicity of DNA-damaging agents. PARP nuclear enzymes are activated by DNA single or double strand breaks, resulting in the poly(ADP-ribosyl)ation of other nuclear DNA binding proteins involved in DNA repair; poly(ADP-ribosyl)ation contributes to efficient DNA repair and to survival of proliferating cells exposed to mild genotoxic stresses as induced by as oxidants, alkylating agents or ionizing radiation.

1 2D Structure

2D Structure

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide

2.1.2 InChI

InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1

2.1.3 InChI Key

JNAHVYVRKWKWKQ-CYBMUJFWSA-N

2.1.4 Canonical SMILES

CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N

2.1.5 Isomeric SMILES

C[C@@]1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N

2.2 Other Identifiers

2.2.1 UNII

01O4K0631N

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

2. 2-(2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

3. Abt 888

4. Abt-888

5. Abt888

2.3.2 Depositor-Supplied Synonyms

1. 912444-00-9

2. Abt-888

3. Abt 888

4. Abt-888 (veliparib)

5. Veliparib Free Base

6. Abt888

7. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benzo[d]imidazole-4-carboxamide

8. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide

9. 2-[(2r)-2-methyl-2-pyrrolidinyl]-1h-benzimidazole-7-carboxamide

10. Chebi:62880

11. 2-[(r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide

12. Parp-1 Inhibitor Abt-888

13. 912444-00-9 (free Base)

14. 01o4k0631n

15. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benimidazole-4-

16. (2r)-2-(7-carbamoyl-1h-benzimidazol-2-yl)-2-methylpyrrolidinium

17. 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

18. Veliparib (abt-888)

19. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benimidazole-4-carboxamide (veliparib)

20. 2-((2r)-2-methyl-2-pyrrolidinyl)-1h-benzimidazole-7-carboxamide

21. 2-((2r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide

22. Nsc-737664

23. Veliparib [usan:inn]

24. Mfcd16661059

25. Unii-01o4k0631n

26. 78p

27. Veliparib [inn]

28. Veliparib [jan]

29. Veliparib [usan]

30. Abt888 (free Base)

31. (r)-2-(2-methylpyrrolidin-2-yl)-1h-benzo[d]imidazole-7-carboxamide

32. Veliparib [who-dd]

33. Benzimidazole Carboxamide, 3a

34. Mls006010184

35. Veliparib (jan/usan/inn)

36. Schembl422318

37. Chembl506871

38. Gtpl7417

39. Bdbm27135

40. Abt-695

41. Dtxsid90238456

42. Ex-a001

43. Bdbm209932

44. Veliparib (abt-888 Hydrochloride)

45. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-1,3-benzodiazole-4-carboxamide

46. Nsc737664

47. Nsc752840

48. S1004

49. Zinc84610155

50. Akos015951440

51. Akos017343746

52. Ccg-264771

53. Cs-0076

54. Db07232

55. Ex-7209

56. Nsc 737664

57. Nsc-752840

58. Sb16480

59. Ncgc00250404-01

60. Ncgc00250404-15

61. Ac-23330

62. As-19397

63. Hy-10129

64. Smr004701290

65. Abt-888 (veliparib, Nsc 737664)

66. A24888

67. D09692

68. A 861695

69. A-861695

70. J-505211

71. Q7919041

72. Brd-k87142802-001-02-7

73. 1h-benzimidazole-4-carboxamide, 2-((2r)-2-methyl-2-pyrrolidinyl)-

74. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benimidazole-4-carboxamide

75. 2-[(2r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-7-carboxamide

76. 2-[(r)-2-methylpyrrolidin-2-yl]-1h-benzimidazole-4-carboxamide;

77. 1h-benzimidazole-7-carboxamide, 2-((2r)-2-methyl-2-pyrrolidinyl)-

2.4 Create Date

2006-12-11

3 Chemical and Physical Properties

Molecular Formula	C₁₃H₁₆N₄O
Molecular Weight	244.29 g/mol
XLogP3	0.5
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	2
Exact Mass	244.13241115 g/mol
Monoisotopic Mass	244.13241115 g/mol
Topological Polar Surface Area	83.8 Å²
Heavy Atom Count	18
Formal Charge	0
Complexity	348
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Treatment of fallopian tube cancer , Treatment of ovarian cancer , Treatment of peritoneal carcinoma

Treatment of lung carcinoma (small cell and non-small cell carcinoma)

Treatment of breast cancer

Treatment of high-grade glioma

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Poly(ADP-ribose) Polymerase Inhibitors

Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. (See all compounds classified as Poly(ADP-ribose) Polymerase Inhibitors.)

5.2 ATC Code

L - Antineoplastic and immunomodulating agents

L01 - Antineoplastic agents

L01X - Other antineoplastic agents

L01XK - Poly (adp-ribose) polymerase (parp) inhibitors

L01XK05 - Veliparib

Veliparib

Veliparib

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

Filters